|
SOME QUESTIONS AND ANSWERS
What medicines are used to treat diabetes?
Type 1 diabetes is managed through the use of
self-injected insulin to control blood glucose, as
well as through education about aspects of diet,
lifestyle and exercise.
Type 2 diabetes is initially managed by
education on diet and exercise, but in many
people satisfactory control of blood glucose is
only achieved through the use of medication as
well.
Where diet and exercise interventions are not
sufficient to control blood glucose and the
individual is overweight, the oral biguanide
metformin will usually be tried first, if kidney
function is normal. In those who are not
overweight, or who are not considered suitable
for metformin, a sulphonylurea, which
stimulates insulin secretion, is normally used
instead.
Acarbose, which decreases carbohydrate
absorption, may be used in people inadequately
controlled on diet alone or on diet and other oral
blood glucose lowering agents.
If blood glucose control is inadequate with a
single medicine, combinations of oral medicines
can be prescribed. Additional classes of oral
medicines that may be used include meglitinide
analogues, which increase insulin secretion, and glitazones, which reduce insulin resistance and
improve beta-cell function. Glitazones may also
be used as single therapy instead of metformin.
If combinations of oral medicines are insufficient to
control blood glucose, insulin treatment may be
necessary, often together with an oral medicine.
In addition, many people with diabetes require
medicines to control blood pressure or regulate
blood fats and cholesterol. These are mentioned
later, but are not discussed in detail in this booklet.
What are the possible long-term complications of diabetes?
In both type 1 and type 2 diabetes, good control
of blood glucose through diet, exercise and
medication, and of other risk factors such as
hypertension, can prevent complications from
developing, even after several decades. This has
been demonstrated in a number of large clinical
studies, of which perhaps the best known is the
United Kingdom Prospective Diabetes Study
(UKPDS), which followed 5,000 people with type
2 diabetes for 20 years.
Unfortunately, even people whose diabetes is
initially well controlled may go on to develop
problems, especially after many years of living
with diabetes, as hyperglycaemia tends to worsen
over time. This most often causes damage to the
cells lining the blood vessels, certain cells in the
kidney, and peripheral nerve cells.
Damage to small blood vessels is termed
microvascular disease. In the retina of the eye,
it gives rise to sight-impairing damage
(retinopathy). Damage in the kidneys, which affects
their filtering ability, is known as nephropathy.
Damage to peripheral nerves ( neuropathy) results
in chronic pain or loss
of sensation.
Damage to the cells lining the large blood vessels
is known as macrovascular disease, and can
give rise to heart attacks and strokes
as well as circulatory problems (peripheral vascular
disease).
Another common complication of diabetes in men
is erectile dysfunction, affecting about 60 per cent
of men with diabetes over the age of 60. This may
be the result of both nerve damage and damage
to blood vessels, but certain medications needed
by such patients can also be a contributory factor.
In an audit of more than 10,000 patients with
diabetes in Wales, coronary heart disease was the
most common complication to develop in people
with diabetes. Fifty-two per cent of the patients had
no complications, but 25 per cent had coronary
heart disease and over 16 per cent had
retinopathy. Nearly 18 per cent of the patients had
two or more complications.
Another survey, this time on Tayside in Scotland,
has provided data on the annual incidence rates of
various complications in both type 1 and type 2
diabetes.
Diabetic complications -
Incidence/year/1,000 persons |
|
 |
|
| Complication |
Type 1
diabetes |
Type 2
diabetes |
 |
| Angina |
8.8 |
38.4 |
| Heart attack |
8.6 |
21.9 |
| Stroke |
1.1 |
14.2 |
| Amputation* |
3.2 |
3.1 |
| PVD |
5.5 |
13.6 |
| Blindness |
1.1 |
1.6 |
| ESRD |
6.4 |
5.0 |
 |
| Deaths |
14.6 |
50.0 |
|
|
PVD
Peripheral Vascular Disease
ESRD
End Stage Renal Disease,
* lower-limb amputation |
|
The incidence of complications was generally
higher in those with type 2 diabetes, perhaps
reflecting the longer exposure to hyperglycaemia
before they were diagnosed.
|